Načítá se...
Acetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks?
Cardiovascular diseases (CVDs) represent a huge health burden for older patients with diabetes. Acetylsalicylic acid (ASA) has long been used as a cardioprotective agent in primary and secondary prevention of CVD. However, there are important issues regarding the benefits and risks of ASA therapy in...
Uloženo v:
Hlavní autoři: | , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
SAGE Publications
2012
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4110868/ https://ncbi.nlm.nih.gov/pubmed/25083237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098612451267 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|